If the new guideline is EpiPen first, access should not be a luxury

I am a physician with good insurance, but every year we have faced higher out-of-pocket cost for my son’s EpiPen.

Summary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.